Condition
Loss of Muscle Mass
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Enrolling By Invitation1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT06117761Not ApplicableEnrolling By Invitation
Combined Activity and Cognitive Intervention for ICU Survivors
NCT03678233Phase 2Unknown
Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients
Showing all 2 trials